Gufic Biosciences Ltd. benchmarking: Performance to industry peers

Financial

	Gufic Biosciences	Bliss GVS Pharma	Novartis
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	1.28 %	2.7 %	n/a
Financials
5 yr Average ROE	16.89 %	6.83 %	8.11 %
5yr average Equity Multiplier	2.16	1.3	2.72
5yr Average Asset Turnover Ratio	0.75	0.62	0.18
5yr Avg Net Profit Margin	10.24 %	8.7 %	17.12 %
Price to Book	4.73	2.55	3.8
P/E	59.7	26.46	33.36
5yr Avg Cash Conversion Cycle	-15.25 Days	186.56 Days	-23.33 Days
Inventory Days	71.73 Days	54.35 Days	44.27 Days
Days Receivable	106.89 Days	189.93 Days	38.18 Days
Days Payable	179.29 Days	75.78 Days	124.28 Days
5yr Average Interest Coverage Ratio	8.9	14.68	65.43
5yr Avg ROCE	17.89 %	13.27 %	5.91 %
5yr Avg Operating Profit Margin	18.12 %	17.03 %	15.15 %
5 yr average Debt to Equity	0.67	0.11	0.0
5yr CAGR Net Profit	-2.66 %	4.24 %	37.01 %
5yr Average Return on Assets	7.7 %	5.31 %	3.13 %
Shareholdings
Promoter Holding	72.5 %	35.36 %	70.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.5 %	0.32 %	0.0
Change in Mutual Fund Holding (3 Yrs)	2.6 %	0.0	0.0

Business

	Gufic Biosciences	Bliss GVS Pharma	Novartis
Product Wise Break-Up	Product Wise Break-Up Domestic Pharmaceuticals 50.0 CMO 30.0 International 15.0 Active Pharmaceutical Ingredient (API) 5.0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 0	Product Wise Break-Up Anti-fungals 0 Antibiotics 5.0 CMO 0 International 0 0 Anti Malarials 43.0 Muscle Relaxants 0 Proton pump inhibitors 0 Active Pharmaceutical Ingredient (API) 0 Anti-fungal 16.0 Domestic Pharmaceuticals 0 Anti-bacterial 0 Cardiovascular 0 Anti-bacterials 0 Anti Inflammatory 7.0 Others 29.0	Product Wise Break-Up Anti-fungals 0 Anti-biotic 0 CMO 0 International 0 Wholesale of pharmaceuticals and medical goods 100.0 Antimalarial 0 Muscle Relaxants 0 Proton pump inhibitors 0 Active Pharmaceutical Ingredient (API) 0 Anti-fungal, 0 Domestic Pharmaceuticals 0 Anti-bacterial 0 Cardiovascular 0 Anti-bacterials 0 Anti Inflammatory 0
Location Wise Break-Up	Location Wise Break-Up India 79.83 Europe 7.54 Asia Pacific 6.04 Africa 2.95 South America 2.37 North America 1.19 Australia 0.08 Rest of the World 0	Location Wise Break-Up Asia Pacific 0 North America 0 South America 0 Australia 0 India 6.61 Africa 0 Rest of the World 93.39 Europe 0	Location Wise Break-Up Asia Pacific 0 North America 0 South America 0 Australia 0 India 100.0 Africa 0 Rest of the World 0 Europe 0

Gufic Biosciences Ltd.

Gufic Biosciences Ltd.

Financial

Business

SIGN UP FOR FREE